How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?

BACKGROUND: An 88-year-old male with a symptomatic severe low-flow low-gradient aortic stenosis was referred for catheter-based treatment (STS 7.7%). INVESTIGATION: Transthoracic echocardiography showed a severe low-flow low-gradient aortic stenosis (peak velocity of 2.9 m/s, AVA 0.6 cm2, LVEF 30%). CT during work-up revealed an unexpected finding of a large fusiform infrarenal AAA with a diameter of 59 mm, a mural thrombus and dissection. DIAGNOSIS: Severe low-flow low-gradient aortic stenosis and a large fusiform infrarenal AAA with mural thrombus and dissection. MANAGEMENT: The strategy was to treat both conditions in the same setting ("one-stop shop") using a complete percutaneous approach under local anaesthesia. Immediately after transfemoral implantation of an Edwards S3 29 mm, a Medtronic Endurant II endograft was implanted in the abdominal aorta.

[1]  I. Meredith,et al.  Simultaneous transcatheter aortic valve implantation and drive-by endovascular aortic aneurysm repair: a case of lotus valve retrieved and replaced due to an undersized valve after an endovascular aneurysm repair , 2017, Cardiovascular Intervention and Therapeutics.

[2]  T. Walther,et al.  Myocardial injury associated with transcatheter aortic valve implantation (TAVI) , 2016, Clinical Research in Cardiology.

[3]  S. Rex,et al.  General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis. , 2016, Current pharmaceutical design.

[4]  R. Lange,et al.  TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[6]  G. Perlman,et al.  Post-procedural hypertension following transcatheter aortic valve implantation: incidence and clinical significance. , 2013, JACC. Cardiovascular interventions.

[7]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[8]  B. Desjardins,et al.  Increased wall stress of saccular versus fusiform aneurysms of the descending thoracic aorta. , 2011, Annals of vascular surgery.

[9]  A. Mügge,et al.  Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. , 2010, American heart journal.

[10]  P. Serruys,et al.  True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar(R) XL and the TandemHeart(R). , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  W. Laskey,et al.  Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2014, Kardiologia polska.

[13]  Jeroen J. Bax,et al.  Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery , 2004 .